echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Anesthesia Topics > Science: The underlying mechanisms of neuropathic pain affecting millions of people have been discovered, with nuclear transport proteins playing a key role.

    Science: The underlying mechanisms of neuropathic pain affecting millions of people have been discovered, with nuclear transport proteins playing a key role.

    • Last Update: 2020-10-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Neuropathic pain is pain caused by injury or illness affecting the body's sensory nervous system, affecting millions of people and with devastating consequences for their health.
    available treatments are limited, and the underlying mechanisms for controlling the spread of the disease are unclear.
    August 14, 2020, Letizia Marvaldi et al. published a research paper on Science Online entitled "Importin alpha3 regulates chronic pain pathways in peripheral sensory neurons", which found that importin alpha3 ( also known as karyopherin subi alpha4) can control the painful response of sensory neurons around mice.
    the Importin alpha3 gene knock-off or sensory neuron-specific knock-down in mice reduced the response to various harmful stimuli and increased tolerance to nerve pain.
    the inhibition of c-Fos or c-Jun in sensory neurons can reduce nerve pain.
    drug screening found drugs that mimic impportin alpha3 deficiency.
    these drugs reduce nerve pain and reduce c-Fos nuclear positioning.
    , interference with c-Fos nuclear input through importin alpha3 in surrounding neurons can promote analgesic effects.
    , opioids are the most commonly used painkillers and have multiple risks of tolerance and dependence that can lead to considerable abuse.
    of current drug development targets in the field of pain are ion channels and neurotransmitter subjects located in the mass membrane and synapses.
    Importin alpha3 provides another target for molecular identity and subcellular positioning, providing opportunities for future analgesia development.
    , Muhammad Saad Yousuf et al. published a review article in Science entitled "The Importins of Pain", which systematically inventoryed the results of the study.
    neuropathic pain is pain caused by injury or illness affecting the body's sensory nervous system, affecting millions of people and with devastating consequences for their health.
    available treatments are limited, and the underlying mechanisms for controlling the spread of the disease are unclear.
    the Importin alpha subs family is essential for the nucleation of the nucleocytes and is involved in cytosteal transport such as neurons.
    , despite the specific overlap of Impin, difference expression spectrums and different cargo affinity can still adjust specific functions through a single Impin.
    study, the researchers found that importin alpha3, also known as karyopherin sub-base alpha4, controls the painful response of sensory neurons around mice.
    the Importin alpha3 gene knock-off or sensory neuron-specific knock-down in mice reduced the response to various harmful stimuli and increased tolerance to nerve pain.
    the inhibition of c-Fos or c-Jun in sensory neurons can reduce nerve pain.
    drug screening found drugs that mimic impportin alpha3 deficiency.
    these drugs reduce nerve pain and reduce c-Fos nuclear positioning.
    , interference with c-Fos nuclear input through importin alpha3 in surrounding neurons can promote analgesic effects.
    in short.
    the study showed that interfering with c-Fos nuclear input through importin alpha3 in sensory neurons reduced sensitivity to harmful stimuli and provided analgesic effects in particular during the maintenance phase of nerve pain.
    Direct c-Fos inhibition is effective in both the early and maintenance stages of neuropathic pain, suggesting that other ways of c-Fos nuclear input or other transcription factors may control early pain responses, while importin alpha3 play a key role in later chronic pain.
    study found that peripheral sensory neurons are the source of the effects of importin alpha3 on persistent neuropathic pain.
    between DRGs in mice and people, the expression spectrum and levels of importin alpha3 and c-Fos are conservative, and a recent study reported a significant increase in the AP1 family gene in DRGs in patients with neuropathic pain, highlighting the potential of Impin alpha3 as an analgesic.
    chronic pain is currently one of the most common unsealed medical needs due to the limited pain-relief effects of existing drugs and adverse side effects.
    addition, opioids are the most commonly used painkillers, with multiple risks of tolerance and dependence that can lead to considerable abuse.
    of current drug development targets in the field of pain are ion channels and neurotransmitter subjects located in the mass membrane and synapses.
    Importin alpha3 provides another target for molecular identity and subcellular positioning, providing opportunities for future analgesia development.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.